Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

577 Articles

Jon C. Ogg | Aug 28, 2019 at 11:20 AM EDT

7 Giant Mergers Transforming the Face of Corporate America

Many mergers have been announced or have closed, but just seven recent and pending deals have transformed how analysts and…

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 26, 2019 at 3:20 PM EDT

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Both Amgen and Celgene shares made a handy gain on Monday after it was announced that the companies had made…

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 7, 2019 at 11:15 AM EDT

Defensive Stocks Standing Strong as Broader Stock Market Indexes Tank

24/7 Wall St. has taken a look at the defensive stocks that are holding up fine on a day that…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | May 28, 2019 at 8:50 AM EDT

Big Pharma Short Sellers Hike Their Bets

The May 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 20, 2019 at 8:45 AM EDT

Top Analyst Upgrades and Downgrades: Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics, Target, United Continental and More

The top analyst upgrades, downgrades and initiations seen on Monday included Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics,…

Chris Lange | May 10, 2019 at 10:15 AM EDT

Big Pharma Scares Off Short Sellers

The April 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | May 3, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts,…

1 … 11 12 13 14 15 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

7 Giant Mergers Transforming the Face of Corporate America

Big Pharma Sees a Rising Tide in Short Interest

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Defensive Stocks Standing Strong as Broader Stock Market Indexes Tank

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics, Target, United Continental and More

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

7 Giant Mergers Transforming the Face of Corporate America

Big Pharma Sees a Rising Tide in Short Interest

Is Amgen Overpaying for Celgene’s Psoriasis Treatment?

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Defensive Stocks Standing Strong as Broader Stock Market Indexes Tank

Short Sellers Up the Ante in Big Pharma

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Short Sellers Seek Direction on Big Pharma

Big Pharma Sees a Rising Tide in Short Interest

Big Pharma Short Sellers Hike Their Bets

Top Analyst Upgrades and Downgrades: Alibaba, Baidu, Bristol-Myers, Cimarex, Deere, Deutsche Bank, Micron, NeoPhotonics, Target, United Continental and More

Big Pharma Scares Off Short Sellers

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do